just a few days ago, they eliminated their neuroscience program prior to the gfk. why? because they don't know enough. the field has been limited to relative hypotheses. there hasn't been that depth of analysis needed to truly understand what the molecular underpinnings are of this disease. >> has the money shifted towards cancer? >> the money has shifted towards cancer. i believe going forward, it will go towards all these age-related disease. cancer is way ahead because the technologies that can now be brought to bear on understanding cancer is critically important. but it's also very important to emphasize that at that pre-clinical space, we've got to invent new organizational constructs in order to systemically drive discoveries, two points of visibility that the private sector can then take down the field. at md anderson, what we're doing is using my entrepreneurial background and what's going on in the field at large to organize ourselves differently so that we can generate an expressway of activities that allows us very definitively to do the experiments needed t